The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer

Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP, de la Chapelle A (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338:1481–1487 Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomaki P, Mecklin JP, Jarvinen HJ (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214–218 Adamson AW, Beardsley DI, Kim WJ, Gao Y, Baskaran R, Brown KD (2005) Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2. Mol Biol Cel 16:1513–1526 Aubry MC, Halling KC, Myers JL, Tazelaar HD, Yang P, Thibodeau SN (2001) DNA mismatch repair genes hMLH1, hMSH2, and hMSH6 are not inactivated in bronchioloalveolar carcinomas of the lung. Cancer 92:2898–2901 Bapat BV, Madlensky L, Temple LK, Hiruki T, Redston M, Baron DL, Xia L, Marcus VA, Soravia C, Mitri A, Shen W, Gryfe R, Berk T, Chodirker BN, Cohen Z, Gallinger S (1999) Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum Genet 104:167–176 Bertrand P, Tishkoff DX, Filosi N, Dasgupta R, Kolodner RD (1998) Physical interaction between components of DNA mismatch repair and nucleotide excision repair. Proc Natl Acad Sci USA 95:14278–14283 Boland CR (2000) Molecular genetics of hereditary nonpolyposis colorectal cancer. Ann NY Acad Sci 910:50–61 Brown KD, Rathi A, Kamath R, Beardsley DI, Zhan Q, Mannino JL, Baskaran R (2003) The mismatch repair system is required for S-phase checkpoint activation. Nat Genet 33:80–84 Caduff RF, Johnston CM, Svoboda-Newman SM, Poy EL, Merajver SD, Frank TS (1996) Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 148:1671–1678 Castrilli G, Fabiano A, La Torre G, Marigo L, Piantelli C, Perfetti G, Ranelletti FO, Piantelli M (2002) Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in salivary gland tumors. J Oral Pathol Med 31:234–238 Cejka P, Stojic L, Mojas N, Russell AM, Heinimann K, Cannavo E, di Pietro M, Marra G, Jiricny J (2003) Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J 22:2245–2254 Charames GS, Bapat B (2003) Genomic instability and cancer. Curr Mol Med 3:589–596 Claij N, Te Riele H (2002) Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level. Oncogene 21:2873–2879 Cleaver JE (1968) Defective repair replication of DNA in xeroderma pigmentosum. Nature 218:652–656 Cleaver JE (1969) Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective. Proc Natl Acad Sci USA 63:428–435 Cox EC, Degnen GE, Scheppe ML (1972) Mutator gene studies in Escherichia coli: the mutS gene. Genetics 72:551–567 Dao V, Modrich P (1998) Mismatch-, MutS-, MutL-, and helicase II-dependent unwinding from the single-strand break of an incised heteroduplex. J Biol Chem 273:9202–9207 Fears TR, Scotto J, Schneiderman MA (1977) Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. Am J Epidemiol 105:420–427 Field JK, Kiaris H, Howard P, Vaughan ED, Spandidos DA, Jones AS (1995) Microsatellite instability in squamous cell carcinoma of the head and neck. Br J Cancer 71:1065–1069 Fink D, Aebi S, Howell SB (1998) The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1–6 Fishel R, Lescoe MK, Rao MR (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027–1038 Galio L, Bouquet C, Brooks P (1999) ATP hydrolysis-dependent formation of a dynamic ternary nucleoprotein complex with MutS and MutL. Nucleic Acids Res 27:2325–2331 Genschel J, Littman SJ, Drummond JT, Modrich P (1998) Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutSα. J Biol Chem 273:19895–19901 Goldmacher VS, Cuzick RA Jr, Thilly WG (1986) Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine. J Biol Chem 261:12462–12471 Hafe BD, Robertson SJ (2000b) DNA mismatch repair and genetic instability. Annu Rev Genet 34:359–399 Hafe BD, Minesinger BK, Jinks-Robertson S (2000a) Discrete in vivo roles for the MutL homologs Mlh2p and Mlh3p in the removal of frameshift intermediates in budding yeast. Curr Biol 10:145–148 Hall MC, Matson SW (1999) The Escherichia coli MutL protein physically interacts with MutH and stimulates the MutH-associated endonuclease activity. J Biol Chem 274:1306–1312 Hall MC, Jordan JR, Matson SW (1998) Evidence for a physical interaction between the Escherichia coli methyl-directed mismatch repair proteins MutL and UvrD. EMBO J 17:1535–1541 Hamid AA, Mandai M, Konishi I, Nanbu K, Tsuruta Y, Kusakari T, Kariya M, Kita M, Fujii S (2002) Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma. Cancer 94:997–1005 Hussein MR, Wood GS (2003) hMLH1 and hMSH2 gene mutations are present in radial growth-phase cutaneous malignant melanoma cell lines and can be induced further by ultraviolet-B irradiation. Exp Dermatol 12:872–875 Hussein MR, Sun M, Roggero E, Sudilovsky EC, Tuthill RJ, Wood GS, Sudilovsky O (2002) Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas. Mol Carcinog 34:35–44 Hussein MR, El-Ghorori RM, El-Rahman YG (2006) Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas. Int J Exp Pathol 87:297–306 Iwamoto K, Shinomiya N, Mochizuki H (1999) Different cell cycle mechanisms between UV-induced and X-ray-induced apoptosis in WiDr colorectal carcinoma cells. Apoptosis 4:59–66 Iwanaga R, Komori H, Ohtani K (2004) Differential regulation of expression of the mammalian DNA repair genes by growth stimulation. Oncogene 23:8581–8590 Kat A, Thilly WG, Fang WH, Longley MJ, Li GM, Modrich P (1993) An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci USA 90:6424–6428 Katabuchi H, van Rees B, Lambers AR (1995) Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res 55:5556–5560 Korabiowska M, Brinck U, Ruschenburg I, Honig JF, Stachura J, Droese M (1999) Loss of DNA-mismatch repair gene expression in oral melanomas. Oncol Rep 6:921–923 Korabiowska M, Brinck U, Dengler H, Stachura J, Schauer A, Droese M (2000) Analysis of the DNA mismatch repair proteins expression in malignant melanomas. Anticancer Res 20:4499–4505 Korabiowska M, Ruschenburg I, Schlott T, Kubitz A, Brinck U, Droese M (2001) Relation between DNA ploidy status and the expression of the DNA-mismatch repair genes MLH1 and MSH2 in cytological specimens of melanoma lymph node and liver metastases. Diagn Cytopathol 24:157–162 Korabiowska M, Konig F, Verheggen R, Schlott T, Cordon-Cardo C, Romeike B, Brinck U (2004) Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases. Anticancer Res 24:981–986 Kramer W, Kramer B, Williamson MS, Fogel S (1989) Cloning and nucleotide sequence of DNA mismatch repair gene PMS1 from Saccharomyces cerevisiae: homology of PMS1 to procaryotic MutL and HexB. J Bacteriol 171:5339–5346 Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215–1225 Leach FS, Polyak K, Burrell M (1996) Mutations of the human mismatch repair gene hMSH-2 in normal and neoplastic tissues. Cancer Res 56:235–240 Leach FS, Hsieh JT, Molberg K, Saboorian MH, McConnell JD, Sagalowsky AI (2000) Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy. Cancer 88:2333–2341 Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B, Kinzler KW (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2:169–174 Loeb LA (1994) Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54:5059–5063 Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, Heimdal K, Andersen TI, Moller P, Rognum TO, Fossa SD, Haldorsent T, Langmarg F, Brogger A, De La Chapelle A, Borresen AL (1993) Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53:5849–5852 Lynch HT, Smyrk T, Lynch JF (1998) Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation. Oncology 55:103–108 Marra G, Chang CL, Laghi LA, Chauhan DP, Young D, Boland CR (1996) Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells. Oncogene 13:2189–2196 Mellon I, Champe GN (1996a) Products of DNA mismatch repair genes mutS and mutL are required for transcription-coupled nucleotide-excision repair of the lactose operon in Escherichia coli. Proc Natl Acad Sci USA 93:1292–1297 Mellon I, Rajpal DK, Koi M, Boland CR, Champe GN (1996b) Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 272:557–560 Meyers M, Theodosiou M, Acharya S, Odegaard E, Wilson T, Lewis JE, Davis TW, Wilson-Van Patten C, Fishel R, Boothman DA (1997) Cell cycle regulation of the human DNA mismatch repair genes hMSH2, hMLH1, and hPMS2. Cancer Res 57:206–208 Mu D, Tursun M, Duckett DR, Drummond JT, Modrich P, Sancar A (1997) Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol Cell Biol 17:760–769 Muller A, Fishel R (2002) Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 20:102–109 O’Brien V, Brown R (2006) Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 27:682–692 Painter RB (1981) Radioresistant DNA synthesis: an intrinsic feature of ataxia telangiectasia. Mutat Res 84:183–190 Peters AC, Young LC, Maeda T, Tron VA, Andrew SE (2003) Mammalian DNA mismatch repair protects cells from UVB-induced DNA damage by facilitating apoptosis and p53 activation. DNA Repair (Amst) 2:427–435 Prtilo A, Leach FS, Markwalder R, Kappeler A, Burkhard FC, Cecchini MG, Studer UE, Thalmann GN (2005) Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer. J Urol 174:1814–1818 Prolla T, Christie DM, Liskay RM (1994) Dual requirement in yeast DNA mismatch repair for MLH1 and PMS1, two homologs of the bacterial mutL gene. Mol Cell Biol 14:407–415 Quinn AG, Healy E, Rehman I, Sikkink S, Rees JL (1995) Microsatellite instability in human non-melanoma and melanoma skin cancer. J Invest Dermatol 104:309–312 Rass K, Gutwein P, Muller SM, Friedrich M, Meineke V, Welter C, Tilgen W, Reichrath J (2000) Immunohistochemical analysis of DNA mismatch repair enzyme hMSH-2 in normal human skin and basal cell carcinomas. Histochem J 32:93–97 Rass K, Gutwein P, Tilgen W, Welter C, Meineke V, Reichrath J (2001) DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines. Histochem J 33:459–467 Renault B, Calistri D, Buonsanti G, Nanni O, Amadori D, Ranzani GN (1996) Microsatellite instability and mutations of p53 and TGF-beta RII genes in gastric cancer. Hum Genet 98:601–607 Sancar A, Hearst JE (1993) Molecular matchmakers. Science 259:1415–1420 Sato M, Nishigori C, Zghal M, Yagi T, Takebe H (1993) Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients. Cancer Res 1253:2944–2946 Scherer SJ, Welter C, Zang KD, Dooley S (1996) Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2. Biochem Biophys Res Commun 221:722–728 Scherer SJ, Maier SM, Seifert M, Hanselmann RG, Zang KD, Muller-Hermelink HK, Angel P, Welter C, Schartl M (2000) p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. J Biol Chem 275:37469–37473 Setlow RB, Grist E, Thompson K, Woodhead AD (1993) Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 90:6666–6670 Srivastava T, Chattopadhyay P, Mahapatra AK, Sarkar C, Sinha S (2004) Increased hMSH2 protein expression in glioblastoma multiforme. J Neurooncol 66:51–57 Shia J, Ellis NA, Klimstra DS (2004) The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch 445:431–441 Thibodeau SN, French AJ, Roche PC (1996) Altered expression of hMSH-2 and hMLH-1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56:4836–4840 Umar A, Risinger JI, Glaab WE, Tindall KR, Barrett JC, Kunkel TA (1998) Functional overlap in mismatch repair by human MSH3 and MSH6. Genetics 148:1637–1646 van Oosten M, Stout GJ, Backendorf C, Rebel H, de Wind N, Darroudi F, van Kranen HJ, de Gruijl FR, Mullenders LH (2005) Mismatch repair protein Msh2 contributes to UVB-induced cell cycle arrest in epidermal and cultured mouse keratinocytes. DNA Repair (Amst) 4:81–89 Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R, Khan PM (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020–1027 Wagner R, Meselson M (1976) Repair tracts in mismatched DNA heteroduplexes. Proc Natl Acad Sci USA 73:4135–4139 Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307–320 Wang H, Lawrence CW, Li GM, Hays JB (1999a) Specific binding of human MSH2.MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases. J Biol Chem 274:16894–16900 Wang TF, Kleckner N, Hunter N (1999b) Functional specificity of MutL homologs in yeast: evidence for three Mlh1-based heterocomplexes with distinct roles during meiosis in recombination and mismatch correction. Proc Natl Acad Sci USA 96:13914–13919 Wang Y, Qin J (2003) MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation. Proc Natl Acad Sci USA 100:15387–15392 Watanabe M, Imai H, Kato H, Shiraishi T, Ushijima T, Nagao M, Yatani R (1996) Microsatellite instability in latent prostate cancers. Int J Cancer 69:394–397 Wheeler JM, Loukola A, Aaltonen LA, Mortensen NJ, Bodmer WF (2000) The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers. J Med Genet 37:588–592 Young LC, Peters AC, Maeda T, Edelmann W, Kucherlapati R, Andrew SE, Tron VA (2003) DNA mismatch repair protein Msh6 is required for optimal levels of ultraviolet-B-induced apoptosis in primary mouse fibroblasts. J Invest Dermatol 121:876–880 Young LC, Thulien KJ, Campbell MR, Tron VA, Andrew SE (2004) DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study. Carcinogenesis 25:1821–1827 Zhang H, Richards B, Wilson T, Lloyd M, Cranston A, Thorburn A, Fishel R, Meuth M (1999) Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res 59:3021–3027